MTVA

$1.52

Pre-MarketAs of Mar 17, 8:00 PM UTC

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.

Overview Intraday AnalysisPRO IntelligencePRO Ask AIPRO

Recent News

Simply Wall St.

Simply Wall St.

We're Keeping An Eye On MetaVia's (NASDAQ:MTVA) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Neutral flow. Standard news cycle with no clear sentiment tilt.

MTVA Stock Analysis & Real-Time Data | Whystock